This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 117/11/1369    most recent CIRCULATIONAHA.107.706291v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chakir, K. Articles by Kass, D. A. Search for Related Content PubMed PubMed Citation Articles by Chakir, K. Articles by Kass, D. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure Related Collections Congestive Pacemaker Animal models of human disease Apoptosis Heart failure - basic studies Physiological and pathological control of gene expression Related Article

(Circulation. 2008;117:1369-1377.)
© 2008 American Heart Association, Inc.

Heart Failure

Reversal of Global Apoptosis and Regional Stress Kinase Activation by Cardiac Resynchronization

Khalid Chakir, PhD; Samantapudi K. Daya, MD; Richard S. Tunin, BS; Robert H. Helm, MD; Melissa J. Byrne, PhD; Veronica L. Dimaano, MD; Albert C. Lardo, PhD; Theodore P. Abraham, MD; Gordon F. Tomaselli, MD; David A. Kass, MD

From the Division of Cardiology, School of Medicine, Department of Biomedical Engineering, Johns Hopkins University Medical Institutions, Baltimore, Md.

Correspondence to David A. Kass, MD, Division of Cardiology, Ross Bldg 835, Johns Hopkins University Medical Institutions, 720 Rutland Ave, Baltimore, Md 21205. E-mail dkass{at}jhmi.edu

Received March 28, 2007; accepted January 8, 2008.

Background— Cardiac dyssynchrony in the failing heart worsens global function and efficiency and generates regional loading disparities that may exacerbate stress-response molecular signaling and worsen cell survival. We hypothesized that cardiac resynchronization (CRT) from biventricular stimulation reverses such molecular abnormalities at the regional and global levels.

Methods and Results— Adult dogs (n=27) underwent left bundle-branch radiofrequency ablation, prolonging the QRS by 100%. Dogs were first subjected to 3 weeks of atrial tachypacing (200 bpm) to induce dyssynchronous heart failure (DHF) and then randomized to either 3 weeks of additional atrial tachypacing (DHF) or biventricular tachypacing (CRT). At 6 weeks, ejection fraction improved in CRT (2.8±1.8%) compared with DHF (–4.4±2.7; P=0.02 versus CRT) dogs, although both groups remained in failure with similarly elevated diastolic pressures and reduced dP/dtmax. In DHF, mitogen-activated kinase p38 and calcium-calmodulin–dependent kinase were disproportionally expressed/activated (50% to 150%), and tumor necrosis factor- increased in the late-contracting (higher-stress) lateral versus septal wall. These disparities were absent with CRT. Apoptosis assessed by terminal deoxynucleotide transferase-mediated dUTP nick-end labeling staining, caspase-3 activity, and nuclear poly ADP-ribose polymerase cleavage was less in CRT than DHF hearts and was accompanied by increased Akt phosphorylation/activity. Bcl-2 and BAD protein diminished with DHF but were restored by CRT, accompanied by marked BAD phosphorylation, enhanced BAD–14-3-3 interaction, and reduced phosphatase PP1, consistent with antiapoptotic effects. Other Akt-coupled modulators of apoptosis (FOXO-3 and GSK3β) were more phosphorylated in DHF than CRT and thus less involved.

Conclusions— CRT reverses regional and global molecular remodeling, generating more homogeneous activation of stress kinases and reducing apoptosis. Such changes are important benefits from CRT that likely improve cardiac performance and outcome.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 117: 1353. [Extract] [Full Text]

This article has been cited by other articles:

				A. Cheng, R. H. Helm, and T. P. Abraham Pathophysiological mechanisms underlying ventricular dyssynchrony Europace, November 1, 2009; 11(suppl_5): v10 - v14. [Abstract] [Full Text] [PDF]

				A. S. Barth, T. Aiba, V. Halperin, D. DiSilvestre, K. Chakir, C. Colantuoni, R. S. Tunin, V. L. Dimaano, W. Yu, T. P. Abraham, et al. Cardiac Resynchronization Therapy Corrects Dyssynchrony-Induced Regional Gene Expression Changes on a Genomic Level Circ Cardiovasc Genet, August 1, 2009; 2(4): 371 - 378. [Abstract] [Full Text] [PDF]

				S. Chua, L.-T. Chang, C.-K. Sun, J.-J. Sheu, F.-Y. Lee, A. A. Youssef, C.-H. Yang, C.-J. Wu, and H.-K. Yip Time Courses of Subcellular Signal Transduction and Cellular Apoptosis in Remote Viable Myocardium of Rat Left Ventricles Following Acute Myocardial Infarction: Role of Pharmacomodulation Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 104 - 115. [Abstract] [PDF]

				J. A. Dixon and F. G. Spinale Large Animal Models of Heart Failure: A Critical Link in the Translation of Basic Science to Clinical Practice Circ Heart Fail, May 1, 2009; 2(3): 262 - 271. [Abstract] [Full Text] [PDF]

				K. Chakir, S. K. Daya, T. Aiba, R. S. Tunin, V. L. Dimaano, T. P. Abraham, K. Jaques, E. W. Lai, K. Pacak, W.-Z. Zhu, et al. Mechanisms of Enhanced {beta}-Adrenergic Reserve From Cardiac Resynchronization Therapy Circulation, March 10, 2009; 119(9): 1231 - 1240. [Abstract] [Full Text] [PDF]

				T. Aiba, G. G. Hesketh, A. S. Barth, T. Liu, S. Daya, K. Chakir, V. L. Dimaano, T. P. Abraham, B. O'Rourke, F. G. Akar, et al. Electrophysiological Consequences of Dyssynchronous Heart Failure and Its Restoration by Resynchronization Therapy Circulation, March 10, 2009; 119(9): 1220 - 1230. [Abstract] [Full Text] [PDF]

				P. Castellant, M. Fatemi, E. Orhan, Y. Etienne, and J. J. Blanc Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution Europace, March 1, 2009; 11(3): 350 - 355. [Abstract] [Full Text] [PDF]

				M. N. Faddis A dose response for cardiac resynchronization therapy? J. Am. Coll. Cardiol., January 27, 2009; 53(4): 361 - 362. [Full Text] [PDF]

				G.-C. Fan, X. Zhou, X. Wang, G. Song, J. Qian, P. Nicolaou, G. Chen, X. Ren, and E. G. Kranias Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity Circ. Res., November 21, 2008; 103(11): 1270 - 1279. [Abstract] [Full Text] [PDF]

				K. Chakir, R. S Tunin, T. Aiba, G. Tomaselli, and D. A Kass Abstract 4341: Dyssynchrony is a Prerequisite condition for Beta Reserve Upregulation By Cardiac Resynchronization Therapy Circulation, October 28, 2008; 118(18_MeetingAbstracts): S_868 - S_868.

				J. Abraham and T. P. Abraham Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy?: Echocardiography Is Useful Before Cardiac Resynchronization Therapy if QRS Duration Is Available Circ Cardiovasc Imaging, July 1, 2008; 1(1): 79 - 85. [Full Text] [PDF]

				A. Auricchio and F. W. Prinzen Update on the pathophysiological basics of cardiac resynchronization therapy Europace, July 1, 2008; 10(7): 797 - 800. [Abstract] [Full Text] [PDF]